ABLYNX ANNOUNCES WARRANT EXERCISE
Apr 22, 2016 05:07 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, April 22, 2016 --Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that...

Competition as a fetish: why universities need to escape the trap
Apr 21, 2016 23:47 pm UTC| Insights & Views Business
Competition has colonised our world. Everywhere we go and every step we take, we hear the siren call of competition. Higher education, too, is trapped in a competition fetish. A fetish is the belief in something having...
HILCO REDEVELOPMENT PARTNERS AND EXELON COMPLETE SALE OF NEW BOSTON GENERATING STATION
Apr 21, 2016 22:02 pm UTC| Business
BOSTON, April 21, 2016 -- Hilco Redevelopment Partners, a unit of Hilco Global, and their development partner, Redgate, have completed a transaction with Exelon Generation Co. to purchase the New Boston Generating Station...
Cimcor's compliance solutions wins Cybersecurity Excellence Award
Apr 21, 2016 20:59 pm UTC| Business
CHICAGO, April 21, 2016 -- Cimcor, Inc. has been awarded the 2016 Cybersecurity Excellence Award in the Compliance Solution category for CimTrak, a critical component in the IT compliance and security strategy of...
500 Expected at Third Annual Minne Lusa Health Fair
Apr 21, 2016 20:11 pm UTC| Business
Nebraska Methodist College will host its third annual health fair at Minne Lusa Elementary School. Numerous Omaha organizations will take part in this event, which centers on health promotion and community. OMAHA, Neb.,...
Konica Minolta Expands its Footprint with Baltimore-based Action Business Systems (ABS)
Apr 21, 2016 20:06 pm UTC| Business
RAMSEY , N.J., April 21, 2016 -- Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) announced today that it has completed the strategic acquisition of Action Business Systems (ABS), a Baltimore-based...
Galapagos reports additional data with filgotinib from the Phase 2 FITZROY study
Apr 21, 2016 20:04 pm UTC| Business
Filgotinib: an investigational JAK-inhibitor shows efficacy in Crohn's disease Clinical responses continued from week 10 to week 20 Safety profile similar to that previously observed Phase 3 program in Crohn's...